HALO
Price
$40.73
Change
+$0.65 (+1.62%)
Updated
Mar 27, 6:59 PM EST
40 days until earnings call
PRTA
Price
$25.16
Change
+$0.41 (+1.66%)
Updated
Mar 27, 6:59 PM EST
40 days until earnings call
Ad is loading...

Compare trend and price HALO vs PRTA

Header iconHALO vs PRTA Comparison
Open Charts HALO vs PRTABanner chart's image
Halozyme Therapeutics
Price$40.73
Change+$0.65 (+1.62%)
Volume$307.94K
CapitalizationN/A
Prothena
Price$25.16
Change+$0.41 (+1.66%)
Volume$341.08K
CapitalizationN/A
View a ticker or compare two or three
HALO vs PRTA Comparison Chart

Loading...

HALODaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRTADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
HALO vs. PRTA commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a StrongBuy and PRTA is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (HALO: $40.73 vs. PRTA: $25.13)
Brand notoriety: HALO and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 42% vs. PRTA: 65%
Market capitalization -- HALO: $5.17B vs. PRTA: $1.35B
HALO [@Biotechnology] is valued at $5.17B. PRTA’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, HALO is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 5 TA indicator(s) are bullish while PRTA’s TA Score has 3 bullish TA indicator(s).

  • HALO’s TA Score: 5 bullish, 5 bearish.
  • PRTA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, HALO is a better buy in the short-term than PRTA.

Price Growth

HALO (@Biotechnology) experienced а +0.87% price change this week, while PRTA (@Biotechnology) price change was -1.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

HALO is expected to report earnings on May 07, 2024.

PRTA is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for HALO with price predictions.
OPEN
A.I.dvisor published
a Summary for PRTA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HALO($5.18B) has a higher market cap than PRTA($1.35B). PRTA has higher P/E ratio than HALO: PRTA (21.88) vs HALO (19.40). HALO YTD gains are higher at: 10.200 vs. PRTA (-30.848). HALO has higher annual earnings (EBITDA): 452M vs. PRTA (-190.11M). PRTA has more cash in the bank: 619M vs. HALO (336M). PRTA has less debt than HALO: PRTA (11.8M) vs HALO (1.5B). HALO has higher revenues than PRTA: HALO (829M) vs PRTA (91.4M).
HALOPRTAHALO / PRTA
Capitalization5.18B1.35B383%
EBITDA452M-190.11M-238%
Gain YTD10.200-30.848-33%
P/E Ratio19.4021.8889%
Revenue829M91.4M907%
Total Cash336M619M54%
Total Debt1.5B11.8M12,703%
FUNDAMENTALS RATINGS
HALO vs PRTA: Fundamental Ratings
HALO
PRTA
OUTLOOK RATING
1..100
728
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
3674
SMR RATING
1..100
1095
PRICE GROWTH RATING
1..100
5085
P/E GROWTH RATING
1..100
8392
SEASONALITY SCORE
1..100
47n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRTA's Valuation (61) in the Biotechnology industry is in the same range as HALO (88). This means that PRTA’s stock grew similarly to HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (36) in the Biotechnology industry is somewhat better than the same rating for PRTA (74). This means that HALO’s stock grew somewhat faster than PRTA’s over the last 12 months.

HALO's SMR Rating (10) in the Biotechnology industry is significantly better than the same rating for PRTA (95). This means that HALO’s stock grew significantly faster than PRTA’s over the last 12 months.

HALO's Price Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for PRTA (85). This means that HALO’s stock grew somewhat faster than PRTA’s over the last 12 months.

HALO's P/E Growth Rating (83) in the Biotechnology industry is in the same range as PRTA (92). This means that HALO’s stock grew similarly to PRTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HALOPRTA
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 20 days ago
72%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
68%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
71%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
HALODaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRTADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDSRX24.130.55
+2.33%
Janus Henderson Small Cap Value R
SIIIX16.350.15
+0.93%
AlphaCentric Strategic Income I
ATWYX21.220.13
+0.62%
AB Tax-Managed Wealth Apprec Strat Adv
RDLCX9.010.03
+0.33%
Columbia Disciplined Growth C
FAGCX164.040.07
+0.04%
Fidelity Advisor Growth Opps I

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with MNKD. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+1.62%
MNKD - HALO
49%
Loosely correlated
-5.50%
AXON - HALO
47%
Loosely correlated
-1.13%
FGEN - HALO
38%
Loosely correlated
+5.53%
BMRN - HALO
37%
Loosely correlated
+1.01%
CPRX - HALO
37%
Loosely correlated
+3.37%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+1.54%
PEPG - PRTA
53%
Loosely correlated
+6.02%
MDXG - PRTA
43%
Loosely correlated
-0.13%
BEAM - PRTA
42%
Loosely correlated
+2.35%
DNLI - PRTA
41%
Loosely correlated
+4.48%
NTLA - PRTA
40%
Loosely correlated
+2.82%
More